Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Philips’ Dr Carla Goulart Peron on AI, equity and the future of care
How can AI expand healthcare access without losing the human touch? Philips’ CMO Dr Carla Goulart Peron shares all.
Read more
Does pharma need more 'social' leaders?
Pharmaceutical companies have embraced the corporate social media account, but many lack the personal touch of a profile run by their leader. The opportunity to connect with employees and patients alike is unbounded; the time to log on is now.
Hey Siri, can I trust you with my health?
While health tech is not set to drive pharma out of business, it is essential that the industry incorporates it into future strategies.
Gravitating towards planet centricity
It is time for the pharmaceutical industry to recognise their duty of care to the planet as well as patients, and drastically reduce their carbon footprint.
How do you solve a problem like pharma waste?
Amidst the public discourse surrounding sustainability and ethical practices, is the problem of pharmaceutical waste. It is imperative that the pharmaceutical industry actively seeks solutions.
Merz's Dr Terri L. Phillips on championing equality in the workplace
Dr Terri L. Phillips, Vice President and Head Global Medical Affairs, Merz, speaks to us about championing women in the workplace, her experience in the US army medical corps, and the changing nature of medical affairs.
Access to Medicine: Mission Possible
Globally, 5 billion people have access to medication, leaving 2 billion, predominantly in the developing world, who do not. As a challenge that only continues to grow in complexity, with ever-changing regulations and continual development of treatments, market access appears to be the pharmaceutical industry’s mission impossible
The history of pharma marketing
Over the past two centuries, the landscape of pharmaceutical marketing has transformed almost beyond recognition. We reflect on the propelling reasons behind such metamorphic change and consider the impact of emerging platforms: from print to radio and from TV to online.
Building a R&D strategy for the modern age
Low levels of return on investment in R&D is an issue that has been bubbling beneath the surface of pharmaceutical companies for some time and the situation is coming to a head, threatening the industry’s future
Loading posts...
« Previous
1
…
28
29
30
31
32
33
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View